Blog

Fluxergy talks

See our latest news, articles, and insights.

Featured blog posts

Fluxergy announces collaboration with National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)

Fluxergy is the first company to utilize the National Institutes of Health Diagnostics Preclinical Services to Support Molecular Platform Development.

Fluxergy announces collaboration with National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)

Fluxergy Joins the Wyss Diagnostics Accelerator’s Industrial Participant Program as an Inaugural Member

Health & Wellness: What Urinalysis Could Say About Your Well-being

Fluxergy Expands Research and Manufacturing Facility in Irvine, CA

Thermal, Wellington To Institute Rapid PCR Testing To Protect Against EHV-1

Global Point of Care (POC) Diagnostics Market to Garner almost USD 50 Billion by 2031 and Grow

COVID-19 Rebound after Taking Paxlovid Likely Due to Insufficient Drug Exposure

Global Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics Market to 2025 - Featuring Abbott Laboratories, Atlas Genetics and Cepheid Among Others - ResearchAndMarkets.com

How Taiwanese Immigrant John Tu Built A $6.5 Billion Fortune From Computer Memory

Tu’s New Beat

Fluxergy invests $30M to produce more point-of-care SARS-CoV-2 tests

Fluxergy Appoints Dr. Ali Tinazli To Lead Commercial Efforts

Fluxergy Announces Partnership with Austere environments Consortium for Enhanced Sepsis Outcomes (ACESO)

Health & Wellness: What Urinalysis Could Say About Your Well-being

Fluxergy showcases the future of point-of-care at ADLM

Celebrating Leadership: Tej Patel Named EY Entrepreneur Of The Year® 2024 Finalist

Core Concepts of Veterinary Hospital Biosecurity: Creating a Custom Plan

Partnership Spotlight: Solis BioDyne

Equine Today: The Importance of Having a Biosecurity Program at Your Practice

Why We Started (TBT): HIV Testing

Fluxergy Food Safety Use Cases: Testing Raw Milk

John Tu Helped Build OC’s Largest Private Company. Now He’s Funding a Device Maker to Fight the Spread of COVID-19.

Slow the Spread

4 Tips for Salmonella PCR Testing Success | Fluxergy July 2022 Newsletter

Fluxergy Joins the Wyss Diagnostics Accelerator’s Industrial Participant Program as an Inaugural Member

Fluxergy Expands Research and Manufacturing Facility in Irvine, CA

We Listened to Your Feedback | Fluxergy June 2022 Newsletter

Fluxergy Equine Status Update

Fluxergy, Inc. Receives CE-IVD Marking for a One-Hour COVID-19 RT-PCR Test and Positions for European Market Entry

Fluxergy Featured in SOLIDWORKS 3DEXPERIENCE World 2021

360 DX: Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

The COVID-19 pandemic has shed light on the need for mass testing

Fluxergy, Mass General Brigham Partner to Evaluate Rapid COVID-19 Molecular Testing System

Fluxergy Announces $30 Million to Expand Manufacturing Capacity of its One-Hour Diagnostic System

Fluxergy Submits Request for FDA Emergency Use Authorization (EUA) for One-Hour COVID-19 Test at POC

PCR vs Culture: Pros and Cons of Testing Technologies for Salmonella

Fluxergy Launches New In-House Streptococcus equi ss equi Rapid PCR Assay

Fluxergy's Streptococcus equi ss equi Assay

Streptococcus equi - What Your Clinic Needs to Know

Molecular Testing - Is it Ever Black and White

AAVLD Poster Presentations 2024

Fluxergy Unveils Two New Equine Posters at Upcoming Equine and Veterinary Laboratory Conferences

De Cillo Equine's Dr. Gustavo De Cillo shares how rapid screening changed his practice

Brazos Valley Equine's Dr. Ben Buchanan shares his thoughts on the Fluxergy Platform

Equine Customer Testimonial - Rhinebeck Equine

Equine Customer Testimonial - Steinbeck Equine

Core Concepts of Veterinary Hospital Biosecurity: Creating a Custom Plan

Equine Today: The Importance of Having a Biosecurity Program at Your Practice

Fluxergy Seeks Commercialization Partners for CE-Marked One-Hour COVID-19 Test

Fluxergy announces collaboration with National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID)

Fluxergy showcases the future of point-of-care at ADLM

Why We Started (TBT): HIV Testing

Fluxergy Food Safety Use Cases: Testing Raw Milk

Fluxergy Expands to Scale Up COVID-19 Test Production and Prepare for Testing Beyond COVID-19

John Tu Helped Build OC’s Largest Private Company. Now He’s Funding a Device Maker to Fight the Spread of COVID-19.

Slow the Spread

Fluxergy Announces Partnership with Austere environments Consortium for Enhanced Sepsis Outcomes (ACESO)

Partnership Spotlight: SMARTmedSolutions

Sign up for company updates